-
Signature
-
/s/ Nick Pizzie, Attorney-in-Fact
-
Issuer symbol
-
AXSM
-
Transactions as of
-
27 Aug 2025
-
Transactions value $
-
-$7,303,400
-
Form type
-
4
-
Filing time
-
29 Aug 2025, 19:08:22 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| JEFFS ROGER |
Director |
C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK |
/s/ Nick Pizzie, Attorney-in-Fact |
29 Aug 2025 |
0001231615 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AXSM |
Common Stock |
Sale |
-$2.45M |
-20K |
-15.27% |
$122.30 |
111K |
27 Aug 2025 |
Direct |
F1, F2, F3 |
| transaction |
AXSM |
Common Stock |
Sale |
-$2.43M |
-20K |
-18.02% |
$121.60 |
91K |
28 Aug 2025 |
Direct |
F1, F2, F4 |
| transaction |
AXSM |
Common Stock |
Sale |
-$2.43M |
-20K |
-21.98% |
$121.27 |
71K |
29 Aug 2025 |
Direct |
F1, F2, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: